These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 30415162)

  • 41. Strategies for the treatment of HBV/HDV.
    Krause A; Haberkorn U; Mier W
    Eur J Pharmacol; 2018 Aug; 833():379-391. PubMed ID: 29935174
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Management of hepatitis delta: Need for novel therapeutic options.
    Abbas Z; Abbas M
    World J Gastroenterol; 2015 Aug; 21(32):9461-5. PubMed ID: 26327754
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hepatitis Delta Virus: Replication Strategy and Upcoming Therapeutic Options for a Neglected Human Pathogen.
    Lempp FA; Urban S
    Viruses; 2017 Jul; 9(7):. PubMed ID: 28677645
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chronic Hepatitis D; at a Standstill?
    Rizzetto M
    Dig Dis; 2016; 34(4):303-7. PubMed ID: 27170382
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hepatitis D Virus Infection of Mice Expressing Human Sodium Taurocholate Co-transporting Polypeptide.
    He W; Ren B; Mao F; Jing Z; Li Y; Liu Y; Peng B; Yan H; Qi Y; Sun Y; Guo JT; Sui J; Wang F; Li W
    PLoS Pathog; 2015 Apr; 11(4):e1004840. PubMed ID: 25902143
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Molecular epidemiology of hepatitis B and Delta virus strains that spread in the Mediterranean North East Coast of Tunisia.
    Yacoubi L; Brichler S; Mansour W; Le Gal F; Hammami W; Sadraoui A; Ben Mami N; Msaddek A; Cheikh I; Triki H; Gordien E
    J Clin Virol; 2015 Nov; 72():126-32. PubMed ID: 26513762
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hepatitis B virus infection: co-infection with hepatitis C virus, hepatitis D virus, and human immunodeficiency virus.
    Shukla NB; Poles MA
    Clin Liver Dis; 2004 May; 8(2):445-60, viii. PubMed ID: 15481349
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The adventure of delta.
    Rizzetto M
    Liver Int; 2016 Jan; 36 Suppl 1():135-40. PubMed ID: 26725911
    [TBL] [Abstract][Full Text] [Related]  

  • 49. New Treatments for Chronic Hepatitis B Virus/Hepatitis D Virus Infection.
    Sandmann L; Wedemeyer H
    Clin Liver Dis; 2021 Nov; 25(4):831-839. PubMed ID: 34593156
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An update on HDV: virology, pathogenesis and treatment.
    Alvarado-Mora MV; Locarnini S; Rizzetto M; Pinho JR
    Antivir Ther; 2013; 18(3 Pt B):541-8. PubMed ID: 23792471
    [TBL] [Abstract][Full Text] [Related]  

  • 51. What is the Path Forward to Treat Hepatitis Delta Virus?: Old Treatments and New Options.
    Asselah T
    Clin Liver Dis; 2023 Nov; 27(4):985-995. PubMed ID: 37778781
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Amino Acid Substitutions within HLA-B*27-Restricted T Cell Epitopes Prevent Recognition by Hepatitis Delta Virus-Specific CD8
    Karimzadeh H; Kiraithe MM; Kosinska AD; Glaser M; Fiedler M; Oberhardt V; Salimi Alizei E; Hofmann M; Mok JY; Nguyen M; van Esch WJE; Budeus B; Grabowski J; Homs M; Olivero A; Keyvani H; Rodríguez-Frías F; Tabernero D; Buti M; Heinold A; Alavian SM; Bauer T; Schulze Zur Wiesch J; Raziorrouh B; Hoffmann D; Smedile A; Rizzetto M; Wedemeyer H; Timm J; Antes I; Neumann-Haefelin C; Protzer U; Roggendorf M
    J Virol; 2018 Jul; 92(13):. PubMed ID: 29669837
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hepatitis D virus-induced interferon response and administered interferons control cell division-mediated virus spread.
    Zhang Z; Ni Y; Lempp FA; Walter L; Mutz P; Bartenschlager R; Urban S
    J Hepatol; 2022 Oct; 77(4):957-966. PubMed ID: 35636579
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Resolution of chronic hepatitis Delta after 1 year of combined therapy with pegylated interferon, tenofovir and emtricitabine.
    Mansour W; Ducancelle A; Le Gal F; Le Guillou-Guillemette H; Abgueguen P; Pivert A; Calès P; Gordien E; Lunel F
    J Clin Virol; 2010 Jan; 47(1):97-9. PubMed ID: 19914127
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interplay between Hepatitis D Virus and the Interferon Response.
    Zhang Z; Urban S
    Viruses; 2020 Nov; 12(11):. PubMed ID: 33233762
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ribozyme-independent replication of a defective hepatitis D virus RNA derived from hepatitis B/D patients receiving antiviral therapy.
    Hsu CW; Yeh CT
    Biochem Biophys Res Commun; 2014 Jul; 450(1):616-21. PubMed ID: 24931669
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dynamics of hepatitis D (delta) virus genotype 3 in the Amazon region of South America.
    Alvarado-Mora MV; Romano CM; Gomes-Gouvêa MS; Gutierrez MF; Carrilho FJ; Pinho JR
    Infect Genet Evol; 2011 Aug; 11(6):1462-8. PubMed ID: 21645647
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Increase in HDV replication during steroid therapy - potential implications for testing and treatment strategies.
    Patmore LA; van der Eijk AA; Janssen HLA; de Man RA; Sonneveld MJ
    J Hepatol; 2024 Jul; 81(1):e49-e50. PubMed ID: 38036005
    [No Abstract]   [Full Text] [Related]  

  • 59. Nucleic Acid Polymers Are Active against Hepatitis Delta Virus Infection
    Beilstein F; Blanchet M; Vaillant A; Sureau C
    J Virol; 2018 Feb; 92(4):. PubMed ID: 29212929
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hepatitis D.
    Husa P; Linhartová A; Nemecek V; Husová L
    Acta Virol; 2005; 49(4):219-25. PubMed ID: 16402678
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.